GTO recommends the first few paragraphs of this story from the San Francisco Chronicle, which covers Ernst & Young's recent report on the biotech industry. "Financing from all sources topped $21.3 billion for U.S. biotech companies in 2007, and the $5.5 billion contributed by venture capital firms beat the record set in the heady year of 2000," according to the article.